Overview

Distribution of Tacrolimus in Skin, Atopic Dermatitis

Status:
Completed
Trial end date:
2001-07-01
Target enrollment:
Participant gender:
Summary
This study was designed to further increase the understanding of the pharmacokinetics of tacrolimus in the affected skin of atopic dermatitis patients following repeated topical application of tacrolimus ointment 0.1%.
Phase:
Phase 2
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Tacrolimus